Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy

NCT04588909 is registered in ClinicalTrials.gov with Sheri Kashmir Institute of Medical Sciences as lead sponsor.

NCT NCT04588909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04588909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy
Lead sponsor
Sheri Kashmir Institute of Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
March 23, 2020
Completion date
October 22, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer